Hyperkalemia - 28 Studies Found
| Completed |
: Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months : Hyperkalemia : 2014-06-11 : Drug: Sodium Zirconium Cyclosilicate Acute Phase Dosing: Sodium Zirconium Cyclosilicate 10 g three times |
| Not yet recruiting |
: ZS Ph2/3 Dose-response Study in Japan : Hyperkalemia : 2017-04-05 :
|
| Completed |
: A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) :
: 2013-03-12 :
|
| Completed |
: Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients :
: 2014-02-14 :
|
| Completed |
: Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions : Hyperkalemia : 2013-12-12 : Behavioral: decision support in potassium-inc. drug-drug-interactions display of computer-based reminder |
| Completed |
: POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study : Hyperkalemia : 2015-11-17 : Device: Cardiac rhythm remote monitoring system Non-invasive wearable remote cardiac rhythm monitoring s |
| Terminated |
: An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis : Hyperkalemia : 2014-01-09 : Drug: patiromer 15 grams/day (5 grams 3 times daily) administered orally |
| Completed |
: Relationship Between Potassium Level in Venous Blood Samples Drawn and Heel Sticks In Infants and Newborns : Hyperkalemia : 2011-05-03 :
|
| Completed |
: Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) :
|
| Completed |
: Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia :
|